INARI MEDICAL INC (NARI)

Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Inari Medical, Inc. (NARI)

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI

NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

/PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit...

NARI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

INARI MEDICAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI

INARI ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Inari Medical, Inc. and Encourages Investors to Contact the Firm

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inari Medical, Inc. ("Inari" or the...

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock...

INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI

Grant & Eisenhofer Files Class Action Lawsuit Against Inari Medical, Inc. on Behalf of Institutional Investor

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference

Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference

IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024

NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inari Medical (NASDAQ:NARI) just reported results for the first quarter of 2024...

Inari Medical Reports First Quarter 2024 Financial Results

Inari Medical Reports First Quarter 2024 Financial Results

IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Inari Medical to Announce First Quarter 2024 Financial Results

Inari Medical to Announce First Quarter 2024 Financial Results

IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Inari Medical Announces the Release of 2023 Ethos and Sustainability Report

Inari Medical Announces the Release of 2023 Ethos and Sustainability Report

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...

Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior...

Market Cap Game Show: Andy Cross vs. Bill Mann

Join the "Rule Breaker Investing" fun.

INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws

NEW YORK, NY - (NewMediaWire) - March 20, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc.  (“Inari Medical” or the “Company”) (NASDAQ: NARI).  Click Here to Join Investigation.